Radium Capital surpasses $1 billion in funding milestone
Posted: 5 November 2025 Radium Capital has reached a major milestone, surpassing $1 billion in innovation funding since its founding in 2017 – a benchmark that Managing Director Jeremy Loftus said highlighted that R&D finance is a cornerstone…
Myrio Therapeutics joins Penn Medicine and NYU Langone in collaboration to advance solid tumor T cell immunotherapies
Posted: 28 October 2025 A new international collaboration between Myrio Therapeutics, the University of Pennsylvania’s Perelman School of Medicine, and NYU Langone Health has been formed to accelerate the development of next-generation T cell immunotherapies targeting solid tumours.…
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost collaboration
Posted: 28 October 2025 MTPConnect has formalised a new partnership with the Saudi Ministry of Health through the signing of a Memorandum of Understanding (MoU) at the Global Health Exhibition 2025 in Riyadh. The agreement, signed by MTPConnect…
RMIT University develops cancer-targeting nanodots in international breakthrough
Posted: 27 October 2025 An international research collaboration led by RMIT University has developed tiny metallic particles that selectively kill cancer cells while leaving healthy tissue largely unharmed, marking a promising advance in the design of future cancer…
Telix agent Zircaix® featured in global guidelines for renal imaging
Posted: 24 October 2025 Telix Pharmaceuticals has announced that its investigational PET imaging agent TLX250-CDx (Zircaix®, ⁸⁹Zr-DFO-girentuximab) has been included for the first time in international clinical guidelines for molecular imaging of renal masses. Kevin Richardson, Chief Executive…
Swinburne and partners pioneer AI-driven model to advance precision medicine in muscular dystrophy
Posted: 24 October 2025 A world-first AI-powered disease progression model for facioscapulohumeral muscular dystrophy (FSHD) has been developed through a collaboration between Swinburne University of Technology, the FSHD Global Research Foundation, the National Imaging Facility (NIF), and Springbok…
Immuron launches PROIBS® in Australia
Posted: 24 October 2025 Immuron has officially launched PROIBS®, a new product designed to relieve symptoms of medically diagnosed Irritable Bowel Syndrome (IBS), into the Australian market. The biopharmaceutical company confirmed that pharmacy orders had already been received…
Noxopharm secures first US patent for Sofra™
Posted: 23 October 2025 Noxopharm Limited (ASX:NOX) announced that it had been granted its first United States patent for the company’s Sofra™ technology platform, marking a key milestone in its expanding oncology research portfolio. The patent, issued by…
Chimeric Therapeutics partners with Viral Vector Manufacturing Facility to boost GMP viral vector production
Posted: 17 October 2025 Chimeric Therapeutics (ASX:CHM) has signed a Letter of Intent (LOI) with Viral Vector Manufacturing Facility Pty Ltd (VVMF) to establish a strategic partnership focused on the development and Good Manufacturing Practice (GMP) production of…
Led by Monash University, national Connect-TBI initiative to transform care for traumatic brain injury
Posted: 13 October 2025 A new national data asset initiative, Connect-TBI, funded by the Medical Research Future Fund, is set to transform care for Australians experiencing moderate to severe traumatic brain injury (msTBI). The initiative brings together more…
Immuron files FDA application for Phase II trial of oral IMM-529 in C. difficile infection
Posted: 10 October 2025 Immuron announced it has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for a Phase II clinical trial of its oral therapy IMM-529 targeting Clostridioides difficile infection…
Nutromics unveils world-first real-time multiplexed antibiotic monitoring breakthrough
Posted: 10 October 2025 Nutromics has announced a major milestone in wearable diagnostics, unveiling the world’s first real-time, continuous in vivo data for two antibiotics—vancomycin and tobramycin—measured simultaneously on a single device. The breakthrough was presented at the…
